Babylon Health began with a compelling access thesis: a smartphone could make healthcare easier to reach. Patients could use digital tools, communicate with clinicians, and receive care without starting in a traditional clinic. The company’s ambition was larger than telemedicine. It described a digital-first model that could make high-quality care more accessible and affordable at global scale.

Access is a visible problem, and software can reduce some of its friction. But healthcare delivery is not only an interface. Once a company accepts responsibility for the cost and outcomes of a population, it inherits clinical variability, provider networks, claims, documentation, regulation, and the uncertain timing of medical need.

Babylon moved deeply into that system. In the United States it expanded through value-based care contracts and acquisitions, including Meritage Medical Network. Under capitated arrangements, revenue could grow as membership grew, but the company also assumed responsibility for medical expenses. The performance of the model depended not just on digital engagement, but on accurately estimating and influencing the cost of care.

Revenue changed meaning

Babylon reported that 2022 revenue rose from $320.8 million to approximately $1.11 billion, driven largely by expansion in US value-based care. That number looked like extraordinary growth. Yet much of the revenue was accompanied by the obligation to pay medical claims. Scale increased both the top line and the system the company had to manage.

The 2022 annual report disclosed continuing losses, financing pressure, uncertainty about claims estimates, and substantial doubt about the company’s ability to continue as a going concern. Babylon began cost reductions and sought transactions to provide capital. A proposed take-private transaction later collapsed. In August 2023, two US subsidiaries, Babylon Healthcare Inc. and Babylon Inc., filed for Chapter 7. Core US operations shut down. Later that month, substantially all of the group’s UK assets were sold to eMed through a separate process. These were distinct entities and transactions, not a single worldwide shutdown.

Those financial failures should not be reduced to “telehealth failed.” Virtual care remains useful, and Babylon operated across different markets with different contracts. Nor does a high medical loss ratio by itself prove poor care management. Growth, acquisitions, financing structure, execution, and market conditions all belong in the analysis; the public record does not isolate one cause.

The more durable lesson concerns business-model migration. A company may begin as a technology layer and later become a care-delivery or risk-bearing organization. The mission can sound continuous while the operating system changes completely. Software economics do not automatically survive that transition.

Babylon’s digital front door attracted attention because it made care look more scalable. But the company eventually stood behind more of what happened after the door opened. The question was no longer whether patients could access care. It was whether the organization could coordinate and finance that care sustainably.

Sources and further reading

Entity and transaction descriptions checked November 4, 2026.

Keep exploring

Cityblock Health: What if the missing infrastructure is trust?Forward: Which parts of care can become a product?Put the question to work with an AI prompt →Browse all cases →

For a discussion tailored to your team, explore a workshop with Julien.